Open    Access



Bismuth and Silver Nanoparticles as Antimicrobial Agent over Subgingival Bacterial and Nosocomial Strains



Author(s)

Verónica Campos¹, Argelia Almaguer-Flores², Donaji Velasco-Aria³, David Díaz³ and Sandra E. Rodil⁴

Full-Text PDF XML     1361 Views

DOI:10.17265/2161-6213/2018.7-8.002

1. Facultad de Estomatología, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78000, México
2. Facultad de Odontología, Universidad Nacional Autónoma de México, Mexico City 04510, México
3. Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, México
4. Instituto de Investigación en Materiales, Universidad Nacional Autónoma de México, Mexico City 04510, México

Bismuth compounds are used in the treatment of gastrointestinal infections due to its effectiveness against Helicobacter pylori as Gram-negative bacteria. Moreover, the nanometric materials show better biological properties that the materials in block. The aim of this study was to determine the MICs (minimal inhibitory concentrations) of three colloidal dispersions of bismuth nanoparticles compared with silver nanoparticles against oral and nosocomial bacteria. The nanoparticles were synthesized by chemical reduction in DMSO. The MICs of each colloidal dispersion were obtained on eight species representative of the subgingival biofilm, as well as in three species of medical importance: Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli. All bismuth compounds showed antimicrobial effect on the tested bacterial species, with MICs between 37 to 329 μg/mL. On the other hand, AgNPs showed MICs from 16 to 32 μg/mL for the bacteria of subgingival biofilm and from 32 to 65 μg/mL for the species of medical importance. In accordance with this study, the different BiNPs had an antimicrobial effect in all the bacterial species, although with a potency lower than AgNPs.

Bismuth nanoparticles, silver nanoparticles, subgingival microbiota, Streptococcus aureus, Escherichia coli, Pseudomona aeruginosa.